Results 241 to 250 of about 697,291 (350)

Low Transmission Rate of Hepatitis E Virus by Transfusion of Hepatitis E Virus RNA-Positive Blood Products. [PDF]

Transfus Med Hemother
Sommer-Strunck NM, Plümers R, Vollmer T, Rupp J, Glessing P, Görg S, Hennig H, Juhl D.   +7 more
europepmc   +1 more source

Global Prevalence of Hepatitis E Virus in Swine: A Systematic Review and Meta-analysis

V, Mouna
openalex   +1 more source

Prevalence of hepatitis A virus, hepatitis B virus, hepatitis C virus, hepatitis D virus and hepatitis E virus as causes of acute viral hepatitis in North India: A hospital based study

, 2013
Parul Jain, Shantanu Prakash, Siddharth Gupta, KP Singh, Shakti Saumnam Shrivastava, DD Singh, Jasmeet Singh, Amita Jain   +7 more
openalex   +1 more source

Detection of hepatitis E virus in milk: Current evidence for viral excretion in a wide range of mammalian hosts

, 2022
Sérgio Santos‐Silva, Helena M. R. Gonçalves, Antonio Rivero‐Juárez, Wim H. M. van der Poel, María Säo José Nascimento, João R. Mesquita   +5 more
openalex   +2 more sources

The evolving therapeutic landscape of spinal muscular atrophy – A scoping review of investigational agents, emerging delivery technologies and strategic innovations

British Journal of Clinical Pharmacology, EarlyView.
Spinal muscular atrophy (SMA) is a severe neuromuscular disease with emerging therapeutic complexity. This review aims to systematically map the global pipeline of investigational treatments for SMA. Using ClinicalTrials.gov and complementary international registries, we identified 21 planned or ongoing interventional trials from 2020 to 2025 targeting
Andrej Belančić, Patrick Eustaquio, Elvira Meni Maria Gkrinia, Ivana Stević, Eugen Javor, Yun Wah Lam, Slobodan Janković, Dinko Vitezić   +7 more
wiley   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

, 2022
Hepatology, EarlyView.
Robert J. Fontana, Iris Liou, Adrian Reuben, Ayako Suzuki, M. Isabel Fiel, William Lee, Victor Navarro   +6 more
wiley   +1 more source

Hepatitis E Vaccine Trial in the Royal Nepal Army

, 2001
Mrigendra P. Shrestha, Robert McNair Scott, Laxmi Ram Malla, Durga Man Joshi, Khagendra Bahadur Shrestha, Krishna Narsingh Rayamajhi   +5 more
openalex   +2 more sources

ProTides for Antiviral Activity Beyond Liver Cells

Chemistry – A European Journal, EarlyView.
A strategy for obtaining prodrugs of antiviral nucleotides with broad tissue activity is presented that relies on cycloalkyl or cycloalkylalkyl esters, improving uptake and esterase cleavage, and producing nanomolar inhibitors in kidney, colon, and lung cells.
Felix Goebel, Adrian Humboldt, Heeyoung Kim, Carl J. M. Schölzel, Ralf Bartenschlager, Clemens Richert   +5 more
wiley   +1 more source

Development of Antiviral Therapy against Hepatitis E Virus Infection : on the Basis of Host Factors : Antivirale therapie tegen het Hepatitis E virus: rol van gastheer-specifieke elementen

, 2016
Yijin Wang
openalex   +1 more source

Advancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies

Clinical Pharmacology &Therapeutics, EarlyView.
Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...
Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley, Shakir Atoyebi, Robert Bies, Catriona Waitt, Adeniyi Olagunju   +7 more
wiley   +1 more source